- Home
- M3 Checklist: Multi-Condition Mental Health Screening Tool
Find Locations
For hours, walk-ins and appointments.Nationally-recognized, peer-reviewed and clinically validated, the M3 Checklist – offered exclusively through Labcorp – is a 27-question assessment of mood and anxiety symptoms that can be indicative of four common mental health conditions: anxiety disorders, bipolar disorder, depression and post-traumatic stress disorder (PTSD).
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), any mental illness (or AMI) is defined as “having (currently or at any time in the past year) a diagnosable mental, behavioral, or emotional disorder (excluding developmental and substance use disorders) of sufficient duration to meet diagnostic criteria specified within the DSM-IV, regardless of functional impairment1.”
Routinely evaluating mental health within a primary care setting is an effective way to identify these issues, leading to appropriate diagnoses and treatment. Labcorp is proud to offer an efficient, time saving, and comprehensive tool for screening and monitoring of these issues.
Contact your Labcorp representative to learn more about M3 Checklist and how you can get started using this innovative mental health screening tool.
References
Center of Behavioral Health Statistics and Quality (2015). Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieve from http://www.samhsa.gov/data.
Mental Health Myths and Facts. Us Department of Health and Human Services website. http://mentalhealth.gov/basics/myths-facts/index.html. Updated November 13, 2015.
Gaynes BN, et al. Feasibility and Diagnostic Validity of the M-3 Checklist: A Brief, Self-Rated Screen for Depressive, Bipolar, Anxiety, and Post-Traumatic Stress Disorders in Primary Care. Ann Fam Med 2010;8:160-169.doi:10.1370/afm.1092.
Siu AL. Screening for Depression in Adults: U.S. Preventative Services Task Force Recommendation Statement. JAMA. 2016; 315(4):380-387.